13
Technical Topic: Tumor Targeting Nanoparticles Amanda Stewart 113019128 CHBE333: Sec. 0101 3/30/17

TumorTargetingNanoParticles

Embed Size (px)

Citation preview

Page 1: TumorTargetingNanoParticles

Technical Topic:Tumor Targeting Nanoparticles

Amanda Stewart113019128CHBE333: Sec. 01013/30/17

Page 2: TumorTargetingNanoParticles

OverviewBackgroundProperties and CharacteristicsUses in Cancer TreatmentTypes of Nanoparticles and ApplicationsConclusion

Page 3: TumorTargetingNanoParticles

BackgroundDeveloped with the purpose of improving chemotherapeutics by delivering drug agents more accurately to tumors.

Improve imaging labelsNanoparticles can store payloads within their cores and “targeting” molecules on their surface.

Page 4: TumorTargetingNanoParticles

Nanomedicine Publication/PatentsNanomedicine dominates drug delivery systems with 75% of total sales. Increased interest and study.

Page 5: TumorTargetingNanoParticles

Properties and CharacteristicsNanoparticles are still bigger than most anticancer drugs which makes engineering passive and active targeting more difficult.

Size and surface area can be manipulatedCan control and sustain release through ligands (antibodies or aptamers) or magnetic coatings

Page 6: TumorTargetingNanoParticles

Properties and CharacteristicsNP’s take advantage of existing cellular machinery to deliver drugs.

Accumulate in pathological sites with affected and leaky vasculature

Have been engineered to avoid immune systemPolyethylene glycol (PEG) polymeric layer

Leads to enhanced performance with many dosage levels

Can potentially reduce drug dose needed to achieve effect

Page 7: TumorTargetingNanoParticles

Uses in Cancer TreatmentAlthough not yet tested on humans many nanomedicines are in clinical trials

Select few approved by FDAHard and expensive to mass produce for clinical trials

Promising future for cancer treatment as nanoparticles become better at avoiding healthy tissue

Page 8: TumorTargetingNanoParticles
Page 9: TumorTargetingNanoParticles

NP’s are so small that they can pass through blood vessels to “search” for the cancer tumors. With the targeting moieties, NP’s would be able to differentiate cancer cells from non-cancer cell and thus will not release drugs at the normal cells.

Page 10: TumorTargetingNanoParticles

Nanoparticle ApplicationsGold Nanoparticles are among one of the most studied nanoparticles along with quantum dots, carbon nanotubes, paramagnetic np’s, and liposomes.

Page 11: TumorTargetingNanoParticles

Gold Nanoparticle DesignGNP’s have small size, biocompatibility, high atomic number (Z), and ability to bind to targeting agents (contrast agent potential)“By coating the surface of gold nanoparticles with oligonucleotides, antibodies, peptides, or other bio-recognition molecules, one is then able to recognize specific targets in solution”Coated with PEG and bio-recognition molecules which helps the GNP’s better reach their targeted cells

Page 12: TumorTargetingNanoParticles

ConclusionNP’s can be engineered to be used for targeted drug delivery by attaching “targeting” molecules and encapsulating the drug insideNP’s can be engineering to allow passive and active drug delivery by manipulating their coatings and/or ligandsPromising future for medicine and cancer treatmentOne of the most common NP’s researched for drug delivery for cancer are GNP’s